 | • レポートコード：D0GIR-00276 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、NGSベース診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。NGSベース診断の種類別市場規模（DNAシーケンス、RNAシーケンス、全ゲノムシーケンス、全エクソームシーケンス、その他）、用途別市場規模（病院、クリニック、学術・研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Janssen、Paradigm Diagnostics、ThermoFisher Scientific、Roche、Pacific Biosciences、Qiagen、Admera Health、Illumina、Oxford Gene Technology、Innogene Kalbiotech、AITbiotech、iGenomX、Centogene、Phalanx Biotech Group ・地域別グローバル市場分析 2015年-2020年 ・NGSベース診断の北米市場（アメリカ、カナダ、メキシコ） ・NGSベース診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・NGSベース診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・NGSベース診断の南米市場（ブラジル、アルゼンチン） ・NGSベース診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：DNAシーケンス、RNAシーケンス、全ゲノムシーケンス、全エクソームシーケンス、その他 ・用途別分析：病院、クリニック、学術・研究機関 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global NGS Based Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The NGS Based Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
NGS Based Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, NGS Based Diagnostics market has been segmented into:
DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other
By Application, NGS Based Diagnostics has been segmented into:
Hospitals
Clinics
Academics/Research Institutions
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NGS Based Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level NGS Based Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NGS Based Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the NGS Based Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and NGS Based Diagnostics Market Share Analysis
NGS Based Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NGS Based Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NGS Based Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in NGS Based Diagnostics are:
Janssen
Paradigm Diagnostics
ThermoFisher Scientific
Roche
Pacific Biosciences
Qiagen
Admera Health
Illumina
Oxford Gene Technology
Innogene Kalbiotech
AITbiotech
iGenomX
Centogene
Phalanx Biotech Group
Table of Contents
1 NGS Based Diagnostics Market Overview
1.1 Product Overview and Scope of NGS Based Diagnostics
1.2 Classification of NGS Based Diagnostics by Type
1.2.1 Global NGS Based Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NGS Based Diagnostics Revenue Market Share by Type in 2019
1.2.3 DNA Sequencing
1.2.4 RNA Sequencing
1.2.5 Whole Genome Sequencing
1.2.6 Whole Exome Sequencing
1.2.7 Other
1.3 Global NGS Based Diagnostics Market by Application
1.3.1 Overview: Global NGS Based Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Global NGS Based Diagnostics Market by Regions
1.4.1 Global NGS Based Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NGS Based Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NGS Based Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NGS Based Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS Based Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NGS Based Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS Based Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Janssen
2.1.1 Janssen Details
2.1.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Janssen SWOT Analysis
2.1.4 Janssen Product and Services
2.1.5 Janssen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Paradigm Diagnostics
2.2.1 Paradigm Diagnostics Details
2.2.2 Paradigm Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Paradigm Diagnostics SWOT Analysis
2.2.4 Paradigm Diagnostics Product and Services
2.2.5 Paradigm Diagnostics NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 ThermoFisher Scientific
2.3.1 ThermoFisher Scientific Details
2.3.2 ThermoFisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ThermoFisher Scientific SWOT Analysis
2.3.4 ThermoFisher Scientific Product and Services
2.3.5 ThermoFisher Scientific NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pacific Biosciences
2.5.1 Pacific Biosciences Details
2.5.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pacific Biosciences SWOT Analysis
2.5.4 Pacific Biosciences Product and Services
2.5.5 Pacific Biosciences NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Qiagen SWOT Analysis
2.6.4 Qiagen Product and Services
2.6.5 Qiagen NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Admera Health
2.7.1 Admera Health Details
2.7.2 Admera Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Admera Health SWOT Analysis
2.7.4 Admera Health Product and Services
2.7.5 Admera Health NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Illumina SWOT Analysis
2.8.4 Illumina Product and Services
2.8.5 Illumina NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Oxford Gene Technology
2.9.1 Oxford Gene Technology Details
2.9.2 Oxford Gene Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Oxford Gene Technology SWOT Analysis
2.9.4 Oxford Gene Technology Product and Services
2.9.5 Oxford Gene Technology NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Innogene Kalbiotech
2.10.1 Innogene Kalbiotech Details
2.10.2 Innogene Kalbiotech Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Innogene Kalbiotech SWOT Analysis
2.10.4 Innogene Kalbiotech Product and Services
2.10.5 Innogene Kalbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 AITbiotech
2.11.1 AITbiotech Details
2.11.2 AITbiotech Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 AITbiotech SWOT Analysis
2.11.4 AITbiotech Product and Services
2.11.5 AITbiotech NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 iGenomX
2.12.1 iGenomX Details
2.12.2 iGenomX Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 iGenomX SWOT Analysis
2.12.4 iGenomX Product and Services
2.12.5 iGenomX NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Centogene
2.13.1 Centogene Details
2.13.2 Centogene Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Centogene SWOT Analysis
2.13.4 Centogene Product and Services
2.13.5 Centogene NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Phalanx Biotech Group
2.14.1 Phalanx Biotech Group Details
2.14.2 Phalanx Biotech Group Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Phalanx Biotech Group SWOT Analysis
2.14.4 Phalanx Biotech Group Product and Services
2.14.5 Phalanx Biotech Group NGS Based Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NGS Based Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS Based Diagnostics Players Market Share
3.2.2 Top 10 NGS Based Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NGS Based Diagnostics Revenue and Market Share by Regions
4.2 North America NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
5 North America NGS Based Diagnostics Revenue by Countries
5.1 North America NGS Based Diagnostics Revenue by Countries (2015-2020)
5.2 USA NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe NGS Based Diagnostics Revenue by Countries
6.1 Europe NGS Based Diagnostics Revenue by Countries (2015-2020)
6.2 Germany NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NGS Based Diagnostics Revenue by Countries
7.1 Asia-Pacific NGS Based Diagnostics Revenue by Countries (2015-2020)
7.2 China NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
8 South America NGS Based Diagnostics Revenue by Countries
8.1 South America NGS Based Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NGS Based Diagnostics by Countries
9.1 Middle East & Africa NGS Based Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NGS Based Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global NGS Based Diagnostics Market Forecast by Type (2019-2024)
10.3 DNA Sequencing Revenue Growth Rate (2015-2025)
10.4 RNA Sequencing Revenue Growth Rate (2015-2025)
10.5 Whole Genome Sequencing Revenue Growth Rate (2015-2025)
10.6 Whole Exome Sequencing Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global NGS Based Diagnostics Market Segment by Application
11.1 Global NGS Based Diagnostics Revenue Market Share by Application (2015-2020)
11.2 NGS Based Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Academics/Research Institutions Revenue Growth (2015-2020)
12 Global NGS Based Diagnostics Market Size Forecast (2021-2025)
12.1 Global NGS Based Diagnostics Market Size Forecast (2021-2025)
12.2 Global NGS Based Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America NGS Based Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe NGS Based Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NGS Based Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America NGS Based Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NGS Based Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global NGS Based Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NGS Based Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NGS Based Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NGS Based Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Janssen Corporate Information, Location and Competitors
Table 6. Janssen NGS Based Diagnostics Major Business
Table 7. Janssen NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Janssen SWOT Analysis
Table 9. Janssen NGS Based Diagnostics Product and Solutions
Table 10. Janssen NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Paradigm Diagnostics Corporate Information, Location and Competitors
Table 12. Paradigm Diagnostics NGS Based Diagnostics Major Business
Table 13. Paradigm Diagnostics NGS Based Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Paradigm Diagnostics SWOT Analysis
Table 15. Paradigm Diagnostics NGS Based Diagnostics Product and Solutions
Table 16. Paradigm Diagnostics NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. ThermoFisher Scientific Corporate Information, Location and Competitors
Table 18. ThermoFisher Scientific NGS Based Diagnostics Major Business
Table 19. ThermoFisher Scientific NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. ThermoFisher Scientific SWOT Analysis
Table 21. ThermoFisher Scientific NGS Based Diagnostics Product and Solutions
Table 22. ThermoFisher Scientific NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche NGS Based Diagnostics Major Business
Table 25. Roche NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche NGS Based Diagnostics Product and Solutions
Table 28. Roche NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pacific Biosciences Corporate Information, Location and Competitors
Table 30. Pacific Biosciences NGS Based Diagnostics Major Business
Table 31. Pacific Biosciences NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Pacific Biosciences SWOT Analysis
Table 33. Pacific Biosciences NGS Based Diagnostics Product and Solutions
Table 34. Pacific Biosciences NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Qiagen Corporate Information, Location and Competitors
Table 36. Qiagen NGS Based Diagnostics Major Business
Table 37. Qiagen NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Qiagen SWOT Analysis
Table 39. Qiagen NGS Based Diagnostics Product and Solutions
Table 40. Qiagen NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Admera Health Corporate Information, Location and Competitors
Table 42. Admera Health NGS Based Diagnostics Major Business
Table 43. Admera Health NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Admera Health SWOT Analysis
Table 45. Admera Health NGS Based Diagnostics Product and Solutions
Table 46. Admera Health NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Illumina Corporate Information, Location and Competitors
Table 48. Illumina NGS Based Diagnostics Major Business
Table 49. Illumina NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Illumina SWOT Analysis
Table 51. Illumina NGS Based Diagnostics Product and Solutions
Table 52. Illumina NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Oxford Gene Technology Corporate Information, Location and Competitors
Table 54. Oxford Gene Technology NGS Based Diagnostics Major Business
Table 55. Oxford Gene Technology NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Oxford Gene Technology SWOT Analysis
Table 57. Oxford Gene Technology NGS Based Diagnostics Product and Solutions
Table 58. Oxford Gene Technology NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Innogene Kalbiotech Corporate Information, Location and Competitors
Table 60. Innogene Kalbiotech NGS Based Diagnostics Major Business
Table 61. Innogene Kalbiotech NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Innogene Kalbiotech SWOT Analysis
Table 63. Innogene Kalbiotech NGS Based Diagnostics Product and Solutions
Table 64. Innogene Kalbiotech NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. AITbiotech Corporate Information, Location and Competitors
Table 66. AITbiotech NGS Based Diagnostics Major Business
Table 67. AITbiotech NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. AITbiotech SWOT Analysis
Table 69. AITbiotech NGS Based Diagnostics Product and Solutions
Table 70. AITbiotech NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. iGenomX Corporate Information, Location and Competitors
Table 72. iGenomX NGS Based Diagnostics Major Business
Table 73. iGenomX NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. iGenomX SWOT Analysis
Table 75. iGenomX NGS Based Diagnostics Product and Solutions
Table 76. iGenomX NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Centogene Corporate Information, Location and Competitors
Table 78. Centogene NGS Based Diagnostics Major Business
Table 79. Centogene NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. Centogene SWOT Analysis
Table 81. Centogene NGS Based Diagnostics Product and Solutions
Table 82. Centogene NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Phalanx Biotech Group Corporate Information, Location and Competitors
Table 84. Phalanx Biotech Group NGS Based Diagnostics Major Business
Table 85. Phalanx Biotech Group NGS Based Diagnostics Total Revenue (USD Million) (2017-2018)
Table 86. Phalanx Biotech Group SWOT Analysis
Table 87. Phalanx Biotech Group NGS Based Diagnostics Product and Solutions
Table 88. Phalanx Biotech Group NGS Based Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global NGS Based Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 90. Global NGS Based Diagnostics Revenue Share by Players (2015-2020)
Table 91. Global NGS Based Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 92. Global NGS Based Diagnostics Revenue Market Share by Regions (2015-2020)
Table 93. North America NGS Based Diagnostics Revenue by Countries (2015-2020)
Table 94. North America NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Table 95. Europe NGS Based Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific NGS Based Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 97. South America NGS Based Diagnostics Revenue by Countries (2015-2020)
Table 98. South America NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa NGS Based Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Table 101. Global NGS Based Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 102. Global NGS Based Diagnostics Revenue Share by Type (2015-2020)
Table 103. Global NGS Based Diagnostics Revenue Forecast by Type (2021-2025)
Table 104. Global NGS Based Diagnostics Revenue by Application (2015-2020)
Table 105. Global NGS Based Diagnostics Revenue Share by Application (2015-2020)
Table 106. Global NGS Based Diagnostics Revenue Forecast by Application (2021-2025)
Table 107. Global NGS Based Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NGS Based Diagnostics Picture
Figure 2. Global NGS Based Diagnostics Revenue Market Share by Type in 2019
Figure 3. DNA Sequencing Picture
Figure 4. RNA Sequencing Picture
Figure 5. Whole Genome Sequencing Picture
Figure 6. Whole Exome Sequencing Picture
Figure 7. Other Picture
Figure 8. NGS Based Diagnostics Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Academics/Research Institutions Picture
Figure 12. Global NGS Based Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global NGS Based Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global NGS Based Diagnostics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players NGS Based Diagnostics Revenue Market Share in 2019
Figure 21. Global Top 10 Players NGS Based Diagnostics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global NGS Based Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global NGS Based Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 25. Global NGS Based Diagnostics Revenue Market Share by Regions in 2018
Figure 26. North America NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Europe NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. South America NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. North America NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 32. North America NGS Based Diagnostics Revenue Market Share by Countries in 2019
Figure 33. USA NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Canada NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Europe NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe NGS Based Diagnostics Revenue Market Share by Countries in 2019
Figure 38. Germany NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. UK NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. France NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Russia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Italy NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific NGS Based Diagnostics Revenue Market Share by Countries in 2019
Figure 45. China NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Japan NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Korea NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. India NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. South America NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 51. South America NGS Based Diagnostics Revenue Market Share by Countries in 2019
Figure 52. Brazil NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. UAE NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa NGS Based Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Global NGS Based Diagnostics Revenue Share by Type (2015-2020)
Figure 61. Global NGS Based Diagnostics Revenue Share by Type in 2019
Figure 62. Global NGS Based Diagnostics Market Share Forecast by Type (2021-2025)
Figure 63. Global DNA Sequencing Revenue Growth Rate (2015-2020)
Figure 64. Global RNA Sequencing Revenue Growth Rate (2015-2020)
Figure 65. Global Whole Genome Sequencing Revenue Growth Rate (2015-2020)
Figure 66. Global Whole Exome Sequencing Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global NGS Based Diagnostics Revenue Share by Application (2015-2020)
Figure 69. Global NGS Based Diagnostics Revenue Share by Application in 2019
Figure 70. Global NGS Based Diagnostics Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Academics/Research Institutions Revenue Growth Rate (2015-2020)
Figure 74. Global NGS Based Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global NGS Based Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global NGS Based Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America NGS Based Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Europe NGS Based Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific NGS Based Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. South America NGS Based Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa NGS Based Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
創薬におけるDNAシーケンスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The DNA Sequencing In Drug Discovery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- ミネラルベースアジュバントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Mineral-based Adjuvants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 臨床腫瘍学次世代シーケンシング（NGS）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Clinical Oncology Next Generation Sequencing (NGS) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1065.7 million by 2025, from USD 725.1 millio…
- 分子診断及びNATの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics and NAT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Diagn…
- RNAメチル化シーケンスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The RNA Methylation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…